 |
E-DRUG Archives (by thread)
[e-drug] Client's perception on the services provided at Public Pharmacies,
Kester Cyrus
[e-drug] Nominations for a Patient Representative on neglected diseases,
Jaya Banerji
[e-drug] Benzodiazepines use: consistent with recommendations?,
Ciprian Jauca
[e-drug] Client's perception on the services provided at Public Pharmacies(2),
Foppe van MIl
[e-drug] 7-11 March: next WHO Essential Medicines Committee meeting,
Wilbert Bannenberg
[e-drug] measuring affordability of prescriptions?,
Gamal Khalafalla Mohammed
[e-drug] Clinton Foundation announcements?,
James Love
[e-drug] Indigenous Knowledge and Drug Discovery,
Sheila Reiss
[e-drug] UK withdraws paracetamol + dextropropoxyphene combination,
Andy Gray
[e-drug] compounded drugs too lightly regulated? (3),
Sarah Sellers
[e-drug] Clinton Foundation announcements? (2),
Marie de Cenival
[e-drug] Parecoxib (Dynastat, Rayzon),
Larry Sasich
[e-drug] Pharmaceutical Benefits Scheme 2003-2004,
Ken Harvey
[e-drug] Australia - USA Free Trade Agreement & the PBS,
Ken Harvey
[e-drug] Data exclusivity and trials data disclosure - collision?,
Andy Gray
[e-drug] Indigenous Knowledge and Drug Discovery (3),
Malcolm Ross
[e-drug] Indigenous Knowledge and Drug Discovery (5),
Beverley Snell
[e-drug] compounded drugs too lightly regulated? (4),
Sarah Sellers
[e-drug] The Pharmaceutical industry captures patient organisations,
E-Drug
[e-drug] Funding of patient organisations,
PatientView
[e-drug] Use of Color on Product Labels, Labeling and Packaging,
stein
[e-drug] Data exclusivity and trials data disclosure - collision? (2),
Brook Baker
[e-drug] Adverse reactions to complementary medicines,
E-Drug
[e-drug] Data exclusivity and trials data disclosure - collision? (3),
Lalitha N
[e-drug] Funding of patient organisations (2),
Anita Hardon
[e-drug] adverse reactions to complementary medicines (2),
Sarah Sellers
[e-drug] Global Campaign Against Indian Patent Amendment,
Abraham Thomas
[e-drug] Pharmacist-Only Drugs,
Matthew Seamon
[e-drug] Cephalosporines with Probenecid combinations?,
Nagesh Chander Nanda
[e-drug] RFI: Blood Transfusion Safety Materials?,
Moses Karugu
[e-drug] Canada takes amphetamin ADHD drug off the market,
E-Drug
[e-drug] Data exclusivity and trials data disclosure - collision?(5),
Wilbert Bannenberg
[e-drug] Health GAP on Data Exclusivity, CAFTA, USA and Guatemala,
Brook Baker
[e-drug] How to investigate the use of medicines by consumers,
Martin Canas
[e-drug] Oral diclofenac and mealtimes,
Olutayo Adetokunbo
[e-drug] Fluoroquinolones in anti-microbial therapy,
Olutayo Adetokunbo
[e-drug] UK MHRA sought curbs on high dose rosuvastatin,
E-Drug
[e-drug] WHO Comm IPR Innovation & Public Health invites papers/viewpoints,
Charles Clift
[e-drug] Rectal artemisinine for cerebral malaria,
FHJansen
[e-drug] New 7th version MSF Untangling the web of ARV prices,
Fernando Pacual
[e-drug] MDG task force report on access to essential medicines,
E-Drug
[e-drug] What to do about zinc deficiency?,
E-Drug
[e-drug] Rational Drug Policy and management course,
Karin Wiedenmayer
[e-drug] Cephalosporines with Probenecid combinations? (2),
MELVANI, Sharmila
[e-drug] RFI: Duplicate reports in spontaneous ADR systems?,
Niklas Noren
[e-drug] Funding of PatientView and patient organisations (6),
andrew Herxheimer
[e-drug] What to do about zinc deficiency? (2),
Dr. Evert Davila
[e-drug] New MSF document on malaria in the Asia Pacific,
Alyosha Jacobson
[e-drug] Generic AIDS drug licenses,
Joanna Breitstein
[e-drug] ARV's from hetero and aurobindo,
Miriam Naarendorp
[e-drug] Paediatric drug formulations,
Pierre Kayumba
[e-drug] Counterfeit Artesunate Warning Sheet,
Paul Newton
[e-drug] Inappropriate donations to South East Asia,
Kirsten Myhr
[e-drug] COX-2 in New England Journal of Medicine,
Leela McCullough
[e-drug] Growing Artemisia annua, in tropical Africa,
rowland ayo
[e-drug] NIH Public Access Policy,
valeria . frighi
[e-drug] FDA: promethazine and fatal respiratory depression,
E-Drug
[e-drug] Size of the Indian mailbox,
Andy Gray
[e-drug] Neglected diseases - wake up call from WHO,
E-Drug
[e-drug] MDG task force report on access to essential medicines (2),
Wilbert Bannenberg
[e-drug] Selection of ARVs provided under PEPFAR is limited,
E-Drug
[e-drug] Inappropriate donations to South East Asia (2),
James B. Russo
[e-drug] Size of Indian mailbox,
Sumit Ghoshal
[e-drug] Metamizole (Dipyrone) no longer priority medicine in Tajikistan,
Bruno Clary
[e-drug] Regulating ethical drugs in Nigeria,
olatubosun obileye
[e-drug] Prequalification of Procurement Agencies,
E-Drug
[e-drug] Paediatric drug formulations (cont'd),
Pierre Kayumba
[e-drug] Free essential medicines,
rob verhage
[e-drug] Concern in Africa over private doctors giving AIDS drugs,
Leela McCullough
[e-drug] Myths about hospital formularies persist,
E-Drug
[e-drug] Finance dispute halts new malaria treatment project,
E-Drug
[e-drug] Request for articles,
Cimf
[e-drug] Free essential medicines (3),
Carolyn Green
[e-drug] Ibuprofen lysine IM formulation,
Cimf
[e-drug] Repacking medicines in pharmacies (1),
Valeria Frighi
[e-drug] WHO urged to evaluate Kyoto-style medical treaty,
James Love
[e-drug] Training, capacity building for ARV procurement & supply management,
Hilbrand Haak
[e-drug] NEJM on ARVs and scaling up,
E-Drug
[e-drug] Myths about hospital formularies persist (2),
Gordon Schiff
[e-drug] US FDA in crisis on safety issues,
E-Drug
[e-drug] Cotrimoxazol in paediatric HIV, ethics and standards of care,
Andy Gray
[e-drug] Growing Artemisia annua, in tropical Africa (5),
Spring Gombe
[e-drug] Free essential medicines (6),
JBRusso
[e-drug] Free essential medicines (7),
Carolyn Green
[e-drug] MSF writes Indian president on patents & medicines,
Karim Laouabdia-Sellami
Mail converted by MHonArc 2.6.8
|
| |
